ロード中...
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
BACKGROUND AND AIMS: Patients with severe coronavirus disease 2019 (COVID‐19) are at significant risk of thrombotic complications. However, their prothrombotic state is incompletely understood. Therefore, we measured in vivo activation markers of hemostasis, plasma levels of hemostatic proteins, and...
保存先:
| 出版年: | Res Pract Thromb Haemost |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7845083/ https://ncbi.nlm.nih.gov/pubmed/33537537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|